Status:
COMPLETED
Removal of Beta Blocker Drugs by Hemodialysis
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Chronic Kidney Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Eight maintenance hemodialysis patients are given one of four beta blocker drugs (atenolol, bisoprolol, carvedilol, metoprolol) three hours prior to a hemodialysis session. Blood samples and spent dia...
Eligibility Criteria
Inclusion
- at least 18 years of age, receiving hemodialysis three times per week for at least 90 days.
Exclusion
- gastrointestinal or liver disease, body mass index greater than 40 kg/m2, contraindications for receiving a beta blocker (treatment with contraindicated medications, prior adverse reaction, severe reactive airway disease, hemodynamic instability during dialysis).
Key Trial Info
Start Date :
February 27 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 10 2016
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT03361280
Start Date
February 27 2015
End Date
March 10 2016
Last Update
December 4 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.